These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23020582)
1. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. Reimer T; Rohrmann H; Stubert J; Pecks U; Glocker MO; Richter DU; Gerber B J Matern Fetal Neonatal Med; 2013 Feb; 26(3):263-9. PubMed ID: 23020582 [TBL] [Abstract][Full Text] [Related]
2. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919 [TBL] [Abstract][Full Text] [Related]
3. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles. Alahakoon TI; Zhang W; Trudinger BJ; Lee VW J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483 [TBL] [Abstract][Full Text] [Related]
4. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma. Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923 [TBL] [Abstract][Full Text] [Related]
5. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. Aggarwal PK; Chandel N; Jain V; Jha V J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568 [TBL] [Abstract][Full Text] [Related]
6. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525 [TBL] [Abstract][Full Text] [Related]
7. Soluble endoglin in preeclamptic patients with or without HELLP syndrome. Hertig A; Fort J; Lefevre G; Chabbert-Buffet N; Uzan M; Rondeau E; Rozenberg P Am J Obstet Gynecol; 2010 Jun; 202(6):594.e1-4. PubMed ID: 20430360 [TBL] [Abstract][Full Text] [Related]
8. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016 [TBL] [Abstract][Full Text] [Related]
10. Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country. Reyes LM; García RG; Ruiz SL; Broadhurst D; Aroca G; Davidge ST; López-Jaramillo P Growth Factors; 2012 Jun; 30(3):158-66. PubMed ID: 22486210 [TBL] [Abstract][Full Text] [Related]
11. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women. Laskowska M; Laskowska K; Oleszczuk J J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708 [TBL] [Abstract][Full Text] [Related]
12. Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort. Iannaccone A; Reisch B; Mavarani L; Darkwah Oppong M; Kimmig R; Mach P; Schmidt B; Köninger A; Gellhaus A Hypertens Pregnancy; 2022; 41(3-4):159-172. PubMed ID: 35475405 [TBL] [Abstract][Full Text] [Related]
13. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. Young B; Levine RJ; Salahuddin S; Qian C; Lim KH; Karumanchi SA; Rana S J Matern Fetal Neonatal Med; 2010 May; 23(5):366-70. PubMed ID: 19701867 [TBL] [Abstract][Full Text] [Related]
14. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy. Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555 [TBL] [Abstract][Full Text] [Related]
15. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors. Hirashima C; Ohkuchi A; Takahashi K; Suzuki H; Yoshida M; Ohmaru T; Eguchi K; Ariga H; Matsubara S; Suzuki M Hypertens Res; 2011 Feb; 34(2):212-7. PubMed ID: 21048778 [TBL] [Abstract][Full Text] [Related]
16. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829 [TBL] [Abstract][Full Text] [Related]